Nanion has supplied more than five Patchliner screening platforms to academic institutions this year for advanced ion channel research and screening projects.
The Patchliner, a versatile patch clamp screening platform for increased throughput, is used by customers in the pharmaceutical industry, contract research organisations and academic institutions.
This tool is frequently used for academic research, mainly because of the high data quality obtained with the platform and its experimental freedom.
Together with three additional principal investigators, Dr Todd Scheuer and Dr William Catterall invested in both the Patchliner and the Port-a-Patch to form a core facility for ion channel screening and research at Washington University in Seattle.
Scheuer, a research professor at the university's department of pharmacology, said: 'We invested in the Patchliner because of its great experimental flexibility.
'The diversity of our research projects requires a platform capable of high performance with a multitude of ion channels and cells, as well as experimental possibilities such as action potential or primary cell recordings,' he added.
Meanwhile, Dr Steven Petrou, associate director at the Florey Neuroscience Institute and associate professor at the Centre for Neuroscience at Melbourne University in Australia, invested in multiple Patchliners for the university's ion channel core facility.
He said: 'We recently bought several Patchliners to cover the needs of our neuroscience research projects and to establish an ion channel core facility for the wider ion channel research community.
'The Patchliner has unique experimental features including temperature control, internal perfusion and fast solution exchange.
'This, in combination with supporting giga-ohm seals and having a throughput corresponding to 100 dose responses per day, convinced us that Patchliner will be of great use in our current, but also future research projects,' added Petrou.
